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Background: The National Health and Morbidity Survey in 2011 estimated that 35.1% (5.7 million) of Malaysian
adults aged 18 and older suffer from hypertension. Hypertension is still treated by conventional medicine despite
its exact aetiology being unknown. Studies showed that oxidative stress and low availability of nitric oxide (NO)
causes an increase in vascular wall tension and increase blood pressure. Piper sarmentosum (PS) a traditional Malay
herbal plant is well known for its high antioxidant content. Antioxidant is useful in improving cardiovascular
diseases particularly hypertension. Thus, it is beneficial to determine the effect of PS leaves aqueous extract
(Kadukmy™) on the blood pressure, NO level, oxidative stress markers and serum cholesterol level of the
Spontaneous Hypertensive Rats (SHR).
Methods: Rats were devided into five groups consisting of three treatment groups and two control groups.
Baseline blood investigations were done before and following commencement of treatment. Spontaneous
hypertensive rats were treated for 28 consecutive days and the blood pressure was measured weekly.
Results: Kadukmy™ administration showed a significant reduction in systolic blood pressure (SBP), diastolic blood
pressure (DBP) and mean arterial pressure (MAP) (P < 0.05), increased serum NO level (P < 0.05), reduced serum
malondialdehyde (MDA) level (P < 0.05) and reduction of serum total cholesterol level in groups treated with
Kadukmy-1™.
Conclusions: The result of the present study revealed that Kadukmy™ exerts its antioxidant activity to reduce
oxidative stress damage, increase NO production and able to reduce blood pressure and cholesterol level.
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Hypertension is a worldwide public health problem and
it has an increasing prevalence [1,2]. The Malaysian Na-
tional Health and Morbidity Survey (NHMS) in 2011 re-
ported that the prevalence of hypertension in adult
above 18 years of age was 35.1%. The disease involves
multiple systems including cardiovascular, cerebrovascu-
lar and renal. It may lead to morbidity and mortality [3].
Hypertension is contributed by the interaction between
modifiable and non modifiable risk factors including
genetic predisposition, age, gender, high sodium [4] and* Correspondence: zaitonukm@gmail.com
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article, unless otherwise stated.alcohol intake [5], vitamin D deficiency [6], obesity and
physical inactivity [7]. Endothelial dysfunction and over
activity of the sympathetic and renin angiotensin aldos-
terone system were also reported to cause hypertension
[7]. One of the various causes of endothelial dysfunction
involved the formation of reactive oxygen species (ROS).
Excessive bioavailability of ROS causes oxidative stress
phenomena that have been related to the development
and advancement of hypertension [8,9].
Reactive oxygen species may react with molecules such
as protein, lipid or nucleic acid and cause dysfunction or
destruction to these molecules. The human body has
several mechanisms to balance the ROS formation includ-
ing antioxidant enzymes such as catalase, superoxide dis-
mutase and glutathione peroxidase. Study showed thatCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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superoxide to hydrogen peroxide thus reduces the
blood pressure and endothelial dysfunction [7,8]. In
vessel walls, there is an equilibrium between formation
of ROS and availability of antioxidant as to protect the
blood vessel [10]. Oxidative stress phenomenon hap-
pens whenever the ROS and antioxidant homeostasis is
disturbed either by the increase in the level of ROS or
reduced availability of in vivo antioxidant. This may
cause endothelial dysfunction (ED) that leads to spasm
of the blood vessel wall [11].
Endothelial dysfunction causes imbalance of the vaso-
dilator system’s homeostasis especially involving the pro-
duction and metabolism of NO [12]. Insufficient amount
of NO present in the vessel wall results in increased vas-
cular wall tension and increases the blood pressure. Study
showed that long term use of exogenous antioxidant rich
supplement was able to improve blood pressure and ED,
reduced arterial stiffness and atherosclerosis [13,14].
Lipid peroxidation has been recognized as a major
process of cellular injury in animal biological systems.
This occurs when unsaturated lipids are oxidized to form
additional radical species as well as toxic by-products that
can injure the host system. One of the end products of
lipid peroxidation is malondialdehyde (MDA). It is a low
molecular weight substance found in serum, plasma, tis-
sues and urine [15]. In the current practice, MDA assay is
one of the most common methods of estimating oxidative
stress effects on lipids in biological samples.
Previous research showed that high serum lactate de-
hydrogenase (LDH) and creatine phosphokinase (CPK)
are associated with high blood pressure and cardiovascu-
lar disease. This is explained by the theory that high
blood flow leads to acute injury to the muscles. Thus
these myocellular emzymes will leak into the blood in an
uncontrolled hypertensive patients [16]. In one study,
serum LDH is significantly lowered in Gynura Procum-
bens Extract (500 mg/kg)-treated SHRs [17]. Another
study showed that the leaf extract of Napoleona imperia-
lis had significantly lowered the CPK level in adrenaline
induced hypertensive rat compared to control group
[18]. The present study was conducted in order to deter-
mine the antihypertensive effect of Kadukmy™ and ascer-
tain its ability to increase NO level, reduce oxidative
stress and cholesterol level in SHR.
In current medical practice, over 90% of patients were
diagnosed as essential hypertension [19]. Patients who is
diagnosed as essential hypertension is treated by symp-
tomatic approach without identifying the exact cause.
Many drugs prescribed for the treatment of hyperten-
sion do not tackle the underlying problem because the
exact aetiology of hypertension remains unknown. Beta-
blockers and diuretics are known to reduce blood pres-
sure, but it is unable to prevent end organ damage [20].Previous studies showed that other classes of antihyper-
tensive drugs like direct-acting vasodilators, calcium-
channel blockers, angiotensin-converting–enzyme (ACE)
inhibitors, and angiotensin-receptor blockers (ARBs) im-
proves hypertension and delay end organ damage [21].
However, the International Food Information Council
Foundation 2012 reported that only 23% of patient ob-
tained controlled blood pressure with medical treatment.
Thus, current research of hypertension is progressing in
finding the causes of hypertension focusing in prevent-
ing oxidative stress, protecting the blood vessel endothe-
lial wall and end organ damage [8].
Piper sarmentosum (PS) is a herbal plant. It is known
as kaduk in Malaysia and it possesses many potential
bioactivities. Studies have reported its high antioxidant
compounds such as Vitamin E, carotenoids, xantho-
phylls, tannins and phenolics [22]. It also contains
flavanoid that has various beneficial effects against car-
diovascular diseases [22]. PS has other properties such
as anti-inflammatory [23] and antiatherosclerotic [24]
properties. It has been reported to reduce oxidative
stress and able to increase NO production in human
umbilical vein endothelial cells (HUVEC) [25]. Sub-
acute exposure of PS leaves aqueous extract in animal
study is safe and did not show toxic effect [26]. Our re-
search question is whether the antioxidant property of
PS is able to alleviate oxidative stress and increase NO
production thus reducing the blood pressure in SHR
population. Therefore, PS has a great potential to be
developed as the new antihypertensive agent.Methods
Plant material
Fresh PS leaves were collected from a palm oil farm in
Kuantan, Malaysia and authenticated by a plant taxono-
mist from the Forest Research Institute Malaysia (FRIM)
with plant identification number (PID) 240812–17.Preparation of PS leaves aqueous extract (Kadukmy™)
PS leaves were washed with tap water and dried at ambi-
ent temperature for 24 to 36 hours. Dried leaves extrac-
tion procedures were done at the FRIM laboratory. An
amount of 100 grams of dried leaves were added to 900
ml of distilled water and boiled at 80°C for three hours
and then concentrated, followed by freeze-drying. The
powdered form extract was formulated to Kadukmy™
and stored at 4°C until use. Two tests were performed
for testing the antioxidant activity of Kadukmy™
throughout the study, and at the end of the study the
antioxidant activity of Kadukmy™ were 96.21 ± 0.88% by
DPPH radical scavenging and 95.69 ± 0.18% by super-
oxide scavenging method.
Mohd Zainudin et al. BMC Complementary and Alternative Medicine  (2015) 15:54 Page 3 of 10Experimental animals
A total of 32 males, 10 week old SHRs were obtained
from i-DNA Biotechnology (M) Sdn. Bhd. and 6 normo-
tensive Wistar rats were obtained from Animal Unit of
Universiti Kebangsaan Malaysia (UKM). Rats were fed
with commercial Gold coin Malaysia pellet and kept sin-
gly in cages. The room temperature was controlled at
23 ± 3°C, relative humidity of 55 ± 10% and 12 hour light
dark cycle (lights from 0800h to 2000h). Body weights of
rats at the start of treatment were 250 ± 10% g.
After the acclimatization period for 14 days, six SHRs
were divided into a positive control groups and three
treatment groups with eight SHRs in each group. Base-
line blood investigations were done before initiation of
treatment. Normotensive Wistar rats were assigned as
negative control groups with 6 rats in a group. The con-
trol groups received an amount of distilled water accord-
ing to Kadukmy-2™ mg/kg and should not exceed more
than 2 ml/ 100 g body weight. The treatment groups
were given Kadukmy™ at dosage of Kadukmy-0.5™,
Kadukmy-1™ and Kadukmy-2™ mg/kg daily for 28 con-
secutive days. Rats were killed on day-28 in accordance
with animal ethics and protocol of Animal Unit UKM,
Malaysia with approval number PP/FISIO/2011/ZAI-
TON/27-JANUARY/351-JUNE-2011-DECEMBER-2012.
Determination of blood pressure and blood investigations
The blood pressure of rat were measured in conscious,
prewarmed and restrained rats by non-invasive tech-
nique by a plethysmographic tail cuff method using
CODA non-invasive blood pressure (NIBP) system (Kent
Scientific Corporation, USA). Ten determinations were
made in every session of BP measurement and the mean
of three values within 10 mmHg was taken as the BP level.
Serum CPK and LDH were determined in serum sample
using auto analyser in Pathlab Sdn. Bhd. Serum NO level
were measured by QuantiChrom™ Nitric Oxide Assay Kit
(D2NO–100) obtained from i-DNA Biotechnology Sdn.
Bhd. Malaysia. Serum MDA level were measured by MDA
assay procedure by spectrophotometer [21,22].
Statistical analysis
Results were expressed as mean ± standard error of mean
(S.E.M). Statistical significance was determined by analysis
of variance (ANOVA) and Student’s paired t-test. P values
less than 0.05 were considered significant.
Results
Effects of Kadukmy™ of on blood pressure and heart rate
in rats
Oral administration of Kadukmy™ for 28 days showed a
gradual attenuation of systolic blood pressure (SBP),
diastolic blood pressure (DBP) and mean arterial pres-
sure (MAP) in all treatment groups. These results arestatistically significant (P < 0.05) compared to positive
control groups after first week of Kadukmy™ treatment.
There was no significant change observed in the nega-
tive control group. The SBP of treated groups decreased
gradually until the fifth week of the study and showed
significant difference compared to negative control
group (Figure 1). The DBP and MAP of the treated
groups gradually decreased until the fifth week of the
study and showed significant difference compared to
positive control group. However, they did not show sig-
nificant difference compared to negative control at the
third and fifth week of the study (Figures 2, 3). No
changes were observed in the heart rate of all rats
throughout the study period (Figure 4).
Effects of Kadukmy™ on serum NO and MDA level
At the end of the study, the level of serum NO increased
significantly in treatment groups compared to both posi-
tive and negative control groups (Figure 5). Treatment
group of Kadukmy-2™ showed increase in NO concen-
tration by almost five fold in SHR. The MDA levels
reduced significantly in Kadukmy™ treated group
Kadukmy-1™ and Kadukmy-2™ mg/kg compared to posi-
tive control group and baseline MDA level (Figure 6). The
negative control group showed the lowest MDA level and
statistically significant compared to positive control group
and treated group Kadukmy-0.5™. It indicated that
Kadukmy™ treated group with Kadukmy-1™ and
Kadukmy-2™ were able to reduce oxidative stress levels.
Effects of Kadukmy™ on serum cholesterol
Oral administration of Kadukmy™ showed reduction of
total cholesterol level in serum of SHRs in all treated
groups. The group treated with dose Kadukmy-1™
showed significant reduction compared to baseline and
positive control groups. Both control groups showed ele-
vated levels of serum total cholesterol (Figure 7).
Effects of Kadukmy™ on CPK and LDH
Serum LDH was highest in group Kadukmy-1™ mg/kg.
Both serum CPK and LDH showed an elevated pattern
after Kadukmy™ administration. However Serum CPK of
treated groups did not show significant statistical differ-
ence (P > 0.05) compared to the control groups. The
negative control Wistar rats showed the lowest level of
LDH and was statistically significant (P < 0.05) compared
to positive control group (Figures 8, 9).
Discussion
Medicinal herbs have been widely used from ancient time
to date. The writings from Egyptian papyrus and Ancient
Chinese had described the usage of herbs as medicine as
early as 3,000 B.C [27]. Medicinal herbs refer to leaves,







































Figure 1 Systolic blood pressure of rats treated with Kadukmy™. Data are denoted as mean ± S.E.M of n = 8 for treatment groups and n = 6
in the control groups. *P < 0.05; compared to positive control, #P < 0.05; compared to negative control group.
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Organization (WHO) that 80% of individuals worldwide
rely on herbal medicines in primary health care. This is
due to cost effectiveness of the remedies. Thus, natural or
organic remedies have become more popular [28].
PS has been reported to possess high antioxidant com-
pound [22]. In the present study, we also found a very



























Figure 2 Diastolic blood pressure of rats treated with Kadukmy™. Dat
in the control groups. *P < 0.05; compared to positive control, #P < 0.05; coThe activity was found to be 96.21% as compared to
Vitamin C and 95.69% by superoxide dismutase scaven-
ging process. This finding suggests the high antioxidant
activity in Kadukmy™ which helps to balance ROS for-
mation in the body. As the MDA levels were reduced in
the treated groups, it proved the efficacy of the use of
Kadukmy™ which also helped to reduce oxidative stress












a are denoted as mean ± S.E.M of n = 8 for treatment groups and n = 6







































Figure 3 Mean arterial pressure of rats treated with Kadukmy™. Data are denoted as mean ± S.E.M of n = 8 for treatment groups and n = 6
in the control groups. *P < 0.05; compared to positive control, #P < 0.05; compared to negative control group.
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This explains the mechanism of the attenuation of SBP,
DBP and MAP in SHR following daily oral administra-
tion of Kadukmy™ for 28 consecutive days, as seen in the
present our study.
In the present study, the results showed that the ad-
ministration of Kadukmy™ affected SHR DBP more than
SBP. As the DBP was affected more than SBP, it suggests




















Figure 4 Heart rate of rats treated with Kadukmy™. Data are denoted a
control groups.reducing the blood pressure in the present study com-
pared to other factors such as reduced heart rate or
blood volume. This is explained according to La Place’s
Law of the heart whereby, the diameter of the arterioles
is the most dominant factor that determines the diastolic
blood pressure in which the larger the lumen, the lesser
the pressure exerted into it [30,31].
Reduced availability of NO is the hallmark of endothe-






























Figure 5 Serum NO level in rats treated with Kadukmy™. A = Kadukmy-0.5™, B = Kadukmy-1™, C = Kadukmy-2™. Data are denoted as mean ± S.E.M
of n = 8 for treatment groups and n = 6 in the control groups. *P < 0.05; compared to positive control, #P < 0.05; compared to negative control group.
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or bradykinin [34] and a state of proinflammatory and
prothrombotic endothelium due to reduced endothelium-
derived NO (EDNO). This is explained by the function of
EDNO that mediate endothelium dependent vasodilata-

























Figure 6 MDA level in rats treated with Kadukmy™. A = Kadukmy-0.5™,
of n = 8 for treatment groups and n = 6 in the control groups. *P < 0.05; coIn vascular diseases mainly hypertension, the vascular
relaxation and vasodilatation function of endothelium is
suppressed and sometimes abolished when atheroscler-
osis takes place [34]. Therefore it is postulated that se-
vere hypertensive rats will manifest low level of NO.







B = Kadukmy-1™, C = Kadukmy-2™. Data are denoted as mean ± S.E.M

































Figure 7 Serum cholesterol level in rats treated with Kadukmy™. A = Kadukmy-0.5™, B = Kadukmy-1™, C = Kadukmy-2™. Data are denoted as
mean ± SEM of n = 8 for treatment groups and n = 6 in the control groups. *P < 0.05; compared to positive control, αP < 0.05; compared to

































Figure 8 Serum CPK level in rats treated with Kadukmy™. A = Kadukmy-0.5™, B = Kadukmy-1™, C = Kadukmy-2™. Data are denoted as mean ± S.E.
M of n = 8 for treatment groups and n = 6 in the control groups.































Figure 9 Serum LDH level in rats treated with Kadukmy™. A = Kadukmy-0.5™, B = Kadukmy-1™, C = Kadukmy-2™. Data are denoted as mean
± S.E.M of n = 8 for treatment groups and n = 6 in the control groups.
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in this study demonstrated attenuation of blood pressure
and increase NO level. This proved that administration
of Kadukmy™ caused increased NO level in SHR that
acted as vasoprotective agent against ED and eased vas-
cular relaxation.
Oxidative stress is believed to be the common cause of
endothelial dysfunction [37] as it can cause damage to
proteins, deoxyribonucleic acid, lipids and hence may
alter signal transduction in cells. The production of ROS
mainly superoxide and free radicals need to be in equi-
librium with antioxidant availability in biological systems
because oxidative stress refers to a condition when this
equilibrium is disturbed. Antioxidant defence mechan-
ism is either by ROS scavenging (vitamins A, E and C,
glutathione, ubiquinone, and flavonoids) or by enzymatic
(catalase, superoxide dismutase, glutathione peroxidase)
degradation process [10]. As PS has high antioxidant
content [38], in the present study, Kadukmy™ supple-
mentation in SHR reduced the oxidative stress evidenced
by significant reduction of MDA formation compared to
baseline and control group.
Lipid peroxidation is one of the established mecha-
nisms in oxidative stress in biological systems due to
oxidation of unsaturated lipids especially polyunsatur-
ated type that leads to the formation of free radicals and
lipid peroxides that are harmful to viable tissues. Lipid
peroxides are very volatile and are quickly decomposed
to produce many compounds. For example, the polyun-
saturated fatty acid peroxide end product is MDA.Malondialdehyde is available in serum, food, plasma,
tissues and urine as a result of lipid peroxidation and it
is the most commonly reported analytes for estimation
of lipid peroxidation and oxidative stress [39]. Lipid per-
oxidation occurs in response to tissue injury in multiple
disease condition and it may exaggerate tissue damage
[37]. MDA determination represent preliminary view on
the complex process of lipid peroxidation and it acts as
indicator of lipid peroxidation [40].
Lactate dehydrogenase released into the blood stream
affiliates to cardiac tissue damage [13]. The main source
of energy for the heart is dominantly from fat and it also
relies on lactate and glucose as its energy reservoir [30].
LDH is an enzyme that is found in almost all body tissue
and it catalyses the inter conversion of pyruvate to lac-
tate [41] in an anaerobic condition.
The present study shows a high LDH level in treated
groups compared to negative control but no significant
difference compared to positive control group and the
values were within normal range. Thus, it is proven that
administration of Kadukmy™ supplementation for 4
weeks has no effect on cardiac tissue injury in SHR. A
study by Iemitsu et al. in 2003 showed that SHR demon-
strated higher mRNA expression of LDH on the glyco-
lytic pathway in the heart [42]. This explains the lower
LDH level of normotensive Wistar Kyoto rats compared
to SHR in the present study and this may be the reason
for the difference in cardiac function.
CPK is present in variable tissues that rapidly consume
and buffer adenosine triphosphate (ATP), predominantly
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level is associated with injury or stress to the heart [44]
which causes the enzyme to leak into the circulation.
Kim et. al study showed that antihypertensive treatments
by Gynura procumbens cause reduction in CPK level by
48% [17]. Our study showed that the level of CPK was not
affected by Kadukmy™ treatment and was within the nor-
mal clinical range for rats. This finding was in accordance
to the human study that showed serum CPK level was not
associated with the control of hypertension [45].
Study limitations
Specific cardiovascular biomarkers such as creatine kinase
MB (CKMB) and troponin-i and troponin-t are better in-
dicators for hypertension status. However we observed
CPK and LDH level in our study. High-performance liquid
chromatography (HPLC) is also a better method of quan-
tifying of free MDA rather than TBARS methods that de-
tected only MDA bound to TBA which was used in our
study. Therefore, biomarkers that are more sensitive and
specific may be used to confirm the hypertension and oxi-
dative stress status in a future studies.
Conclusions
Kadukmy™ rich antioxidant supplementation causes sig-
nificant reduction in the oxidative stress, increase NO
level in the blood and reduction of serum total choles-
terol that leads to reduction of endothelial dysfunction
and attenuation of blood pressure in treated compared
to untreated SHR. Thus, it contains potentially useful
properties to be assessed for human use as treatment for
hypertension.
Abbreviations
NO: Nitric oxide; PS: Piper sarmentosum; SHR: Spontaneous hypertensive rats;
SBP: Systolic blood pressure; DBP: Diastolic blood pressure; MAP: Mean
arterial pressure; MDA: Malondialdehyde; ROS: Reactive oxygen species;
ED: Endothelial dysfunction; CPK: Creatine phosphokinase; LDH: Lactate
dehydrogenase; S.E.M: Standard error of mean.
Competing interests
The manufacturer of Kadukmy™ was not involved in the design, funding,
implementation or interpretation of the present study. Therefore the authors
declare that there is no competing interest.
Authors’ contributions
MMZ performed the study, analysed the data and prepared the manuscript.
ZZ supervised the work, provided the grants for the study, evaluated the data,
corrected the manuscript and coordinated the study. NAMMN supervised the
work, evaluated the data, corrected the manuscript and coordinated the study.
All authors have read and approved the final manuscript.
Acknowledgments
The authors are grateful to Universiti Kebangsaan Malaysia Medical Centre
(FF–200–2012), Ministry of Higher Education Malaysia (UKM OUP-TKP–20–97/
2010) for funding this project. Special thanks to Prof. Dr. Srijit Das, Assoc. Prof
Dr. Azarisman Shah Mohd. Shah and Prof.Dr. Pakeer Oothuman for editing
the manuscript, and the technical staffs of Physiology and Anatomy
Department of UKM for their endless support.Author details
1Department of Physiology, Faculty of Medicine, Universiti Kebangsaan
Malaysia Medical Center, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur,
Malaysia. 2Department of Basic Medical Sciences (Physiology), Kulliyyah of
Medicine, International Islamic University Malaysia, Jalan Sultan Ahmad Shah,
Bandar Indera Mahkota, 25200, Kuantan Pahang, Malaysia.
Received: 17 February 2014 Accepted: 19 February 2015
References
1. Organization WH. A global brief on hypertension, silent killer, global public
health crisis. 2013. URL http://www.who.int/iris/bitstream/10665/79059/1/
WHO_DCO_WHD_2013_eng.pdf.
2. Cohen DL, Townsend RR, Angell SY, DiPette DJ. The world health
organization recognizes noncommunicable diseases and raised blood
pressure as global health priority for 2025. J Clin Hypertens. 2014;16:624.
3. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al.
Clinical practice guidelines for the management of hypertension in the
community: a statement by the American Society of Hypertension and the
International Society of Hypertension. J Clin Hypertens. 2014;16:14–26.
4. Du S, Neiman A, Batis C. Understanding the patterns and trends of sodium
intake, potassium intake, and sodium to potassium ratio and their effect on
hypertension in China. Am J Clinical Nutr. 2014;99(2):233–343.
5. Eto M, Okayama M, Kumada M, Takeshima T, Aonuma T, Nakamura Y, Eiji K.
Interaction between alcohol habit and gene polymorphism of
neuropeptide y on the risk of essential hypertension. Journal of the
American College of Cardiology. 2014; 63 (12):
6. Ke L, Graubard B, Albanes D, Fraser DR, Weinstein SJ, Virtamo J, et al.
Hypertension, pulse, and other cardiovascular risk factors and vitamin D
status in Finnish men. Am J Hypertens. 2013;26(8):951–6.
7. Oparil S, Zaman M, Calhoun D. Pathogenesis of hypertension. Ann Intern
Med. 2003;139:761–76.
8. Montezano A, Touyz R. Reactive oxygen species, vascular Noxs, and
hypertension: focus on translational and clinical research. Antioxid Redox
Signal. 2014;20(1):164–82.
9. Touyz RM. Reactive oxygen species in vascular biology: role in arterial
hypertension. Expert Rev Cardiovasc Ther. 2003;1(1):91–106.
10. Sciences SG-P for M and N. Archive. Hamostaseologie. 2014;27:5–12.
11. Rodrigo R, González J, Paoletto F. The role of oxidative stress in the
pathophysiology of hypertension. Hypertens Res. 2011;34(4):431–40.
12. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial
dysfunction, oxidative stress, and risk of cardiovascular events in patients
with coronary artery disease. Circulation. 2001;104(22):2673–8.
13. Otsuki T, Shimizu K. Multicomponent supplement containing Chlorella
decreases arterial stiffness in healthy young men. J Clin Biochem Nutr.
2013;53(3):166.
14. Asgary S, Sahebkar A, Afshani MR, Keshvari M, Haghjooyjavanmard S,
Rafieian-Kopaei M. Clinical evaluation of blood pressure lowering, endothelial
function improving, hypolipidemic and anti-inflammatory effects of
pomegranate juice in hypertensive subjects. Phytother Res. 2014;28:193–9.
15. Guichardant M, Valette-Talbi L, Cavadini C, Crozier G, Berger M. Malondialdehyde
measurement in urine. J Chromatography B Biomedical Sci and Application.
1994;655:112–6.
16. Nasim Habibzadeh MA. Is eccentric Exercise is an effective way to reduce
blood pressure. World J Sport Sci. 2014;9(4):39–44.
17. Kim M-J, Lee HJ, Wiryowidagdo S, Kim HK. Antihypertensive effects of
Gynura procumbens extract in spontaneously hypertensive rats. J Med
Food. 2006;9(4):587–90.
18. James O, Friday E, Unekwuojo E. Antihypertensive effect of methanol
extract of napoleona imperialis (p. beauv) in adrenaline induced
hypertensive albino rats. Inter J Biochemistry Res Rev. 2011;1(2):47–57.
19. Li S, Zhu J, Zhang W, Chen Y, Zhang K. Signature microRNA expression
profile of essential hypertension and its novel link to human
cytomegalovirus infection. Circulation. 2011;124(2):175–84.
20. Clinical practice guidelines for management of hypertension. 2013.
[http://www.moh.gov.my/attachments/CPG_Management_of_
Hypertension_4th_Edition.pdf]
21. Medications for treating hypertension - harvard health publications.
[http://www.health.harvard.edu/heart-health/medications-for-treating-
hypertension]
Mohd Zainudin et al. BMC Complementary and Alternative Medicine  (2015) 15:54 Page 10 of 1022. Ugusman A, Zakaria Z, Chua K. Flavanoids of piper sarmentosum and its
cytoprotective effects against oxidative stress. EXCLI J. 2012;11:705–14.
23. Zakaria Z, Patahuddin H. In vivo anti-nociceptive and anti-inflammatory
activities of the aqueous extract of the leaves of piper sarmentosum.
J Ethnopharmacol. 2010;128(1):42–8.
24. Amran A, Zakaria Z, Othman F. Aqueous extract of piper sarmentosum
decreases atherosclerotic lesions in high cholesterolemic experimental
rabbits. Lipids Health Dis. 2010;9(1):44.
25. Ugusman A, Zakaria Z. Piper sarmentosum inhibits ICAM-1 and Nox4 gene
expression in oxidative stress-induced human umbilical vein endothelial
cells. BMC Complement Altern Med. 2011;11(1):31.
26. Mohd Zainudin M, Zakaria Z, Megat Mohd Nordin NA, Othman F. Does oral
ingestion of piper sarmentosum cause toxicity in experimental animals?
Evidence-Based Complementary and Alternative Medicine.
2013; vol ID 705950.
27. Ebbell B. The papyrus ebers: the greatest Egyptian medical document. 1937.
28. Picking D, Younger N, Mitchell S, Delgoda R. The prevalence of herbal
medicine home use and concomitant use with pharmaceutical medicines
in Jamaica. J Ethnopharmacol. 2011;137(1):305–11.
29. Gielen S, Sandri M, Erbs S, Adams V. Exercise-induced modulation of
endothelial nitric oxide production. Current Pharmaceutical J.
2011;12(9):1357–84.
30. Barrett K. Ganong’s review of medical physiology. 2010.
31. Sherwood L. Human physiology: from cells to systems. 2008.
32. Kelm M. The L-arginine-nitric oxide pathway in hypertension. Curr Hypertens
Rep. 2003;5(1):80–6.
33. Furchgott R, Zawadzki J. The obligatory role of endothelial cells in the
relaxation of arterial smooth muscle by acetylcholine. Nature.
1980;288(5789):373–6.
34. Mombouli J, Vanhoutte P. Endothelial dysfunction: from physiology to
therapy. J Mol Cell Cardiol. 1999;31(1):61–74.
35. Ignarro L, Buga G. Endothelium-derived relaxing factor produced and
released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A.
1987;84(24):9265.
36. Panza J, Casino P, Kilcoyne C, Quyyumi A. Role of endothelium-derived nitric
oxide in the abnormal endothelium-dependent vascular relaxation of
patients with essential hypertension. Circulation. 1993;87(5):1468–74.
37. HongZhuan Y, Long L, Jun F. Involvement of reactive oxygen species in
hypertension: its roles, production and therapeutic strategies. British J Med
and Medical Res. 2014;4(14):2771–82.
38. Subramaniam V, Adenan M, Ahmad A, Sahdan R. Natural antioxidants: piper
sarmentosum (Kadok) and morinda elliptica (Mengkudu). Malaysian J Nutr.
2003;9 suppl 1:41–51.
39. Del Rio D, Stewart A, Pellegrini N. A review of recent studies on
malondialdehyde as toxic molecule and biological marker of oxidative
stress. Nutr Metab Cardiovasc Dis. 2005;15(4):316–28.
40. Janero D. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic
indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol
Med. 1990;9(6):515–40.
41. Gropper S, Smith J. Advanced nutrition and human metabolism. 6th ed.
Wadswoth, Belmont, USA: Yolando Cossioo; 2012.
42. Iemitsu M, Miyauchi T, Maeda S. Cardiac hypertrophy by hypertension and
exercise training exhibits different gene expression of enzymes in energy
metabolism. Hypertens Res. 2003;26(10):829–38.
43. Wessels A, Vermeulen J. Spatial distribution of “tissue‐specific” antigens in
the developing human heart and skeletal muscle III. An
immunohistochemical analysis of creatine kinase isoenzyme expression
patterns. Anat Rec. 1992;228(2):163–76.
44. Gibler WB, Lewis LM, Erb RE, Makens PK, Kaplan BC, Vaugh RH, et al. Early
detection of acute myocardial infarction in patients presenting with chest
pain and nondiagnostic ECGs: serial CK-MB sampling in the emergency
department. Ann Emerg Med. 1990;19(12):1359–66.
45. Johnsen S, Lilleng H. Creatine kinase activity and blood pressure in a normal
population: the tromsø study. J Hypertens. 2011;29(1):36–42.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
